Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-17 Sale | 2026-03-19 6:00 pm | Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer | 4,578 | $32.14 | $147,145 | 10,172 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-15 Exercise | 2026-03-17 5:26 pm | N/A 2029-03-15 | Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer | 14,750 | $0 | 59,000 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:22 pm | N/A 2036-02-16 | Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-20 6:17 pm | N/A 2035-03-19 | Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer | 148,000 | $0 | 148,000 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 4:14 pm | N/A 2034-05-14 | Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer | 396,200 | $0 | 396,200 (Direct) | View |